Please provide your email address to receive an email when new articles are posted on . With advancing technology, cataract surgery is now less invasive, resulting in better recovery and outcomes. Not ...

Please provide your email address to receive an email when new articles are posted on . While examining a patient for centration of his Tecnis multifocal IOL (Abbott Medical Optics), I noticed the ...

Santa Ana-based Abbott Medical Optics continues to forge ahead with new products. The maker of eye devices, a unit of Chicago-based Abbott Laboratories, recently introduced two versions of its Tecnis ...

LOS ANGELES — The accommodative Crystalens intraocular lens (IOL) (Bausch + Lomb) achieved better intermediate visual acuity but not as good near visual acuity compared with the ReStor +3 multifocal ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes. 5¶ Experience the ...

Visual acuity, contrast sensitivity, and depth perception are highly interrelated elements of vision and impact health-related quality of life and safety.4,5 IOL data being presented utilize novel ...

Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric II IOLs. In Canada, it received approval for TECNIS Synergy Toric II IOLs. This ...

TECNIS Odyssey IOL, the full range of vision IOL, is also available in the US, Puerto Rico, and Japan. TECNIS PureSee IOL, the purely refractive, extended depth of focus IOL, is also available across ...

Apodized IOLs have a gradual reduction in diffractive step heights from the center to the periphery. [60] This allows for more light to contact the smaller steps in the periphery when the pupil is ...

"TECNIS Odyssey IOL is the fastest growing PC-IOL in the United States, ^ and we are excited to be making it available to more patients around the world. It addresses a significant unmet need for ...